Buruli Ulcer: Mycobacterium Ulcerans DiseaseGerd Pluschke, Katharina Röltgen A major objective of this open access book is to summarize the current status of Buruli Ulcer (BU) research for the first time. It will identify gaps in our knowledge, stimulate research and support control of the disease by providing insight into approaches for surveillance, diagnosis, and treatment of Buruli Ulcer. Book chapters will cover the history, epidemiology diagnosis, treatment and disease burden of BU and provide insight into the microbiology, genomics, transmission and virulence of Mycobacterium ulcerans. |
Other editions - View all
Buruli Ulcer: Mycobacterium Ulcerans Disease Gerd Pluschke,Katharina Röltgen No preview available - 2019 |
Buruli Ulcer: Mycobacterium Ulcerans Disease Gerd Pluschke,Katharina Röltgen No preview available - 2019 |
Common terms and phrases
activities Africa Agents animal antibiotic antimicrobial associated Australia bacteria Benin Buruli ulcer Cameroon caused cell changes Clin clinical combination compared confirmed countries detection diagnosis distribution drug early effects Emerg endemic environment environmental et al factors followed genome Ghana healers healing hospital human identified immune important increased indicated Initiative isolates Japan Johnson laboratory leading lesions license major mice Microbiol mouse Mycobacterium ulcerans disease Mycobacterium ulcerans infection mycolactone Negl Trop Dis observed Organization patients PLoS PLoS Negl Trop Pluschke G population potential present production protective protein recent reference region reported response rifampicin risk samples sequence shinshuense showed skin social specific strains therapy tion tissue toxin transmission treated treatment Tropical tuberculosis ulcerans subsp vaccination weeks wound